ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,638Medicare Part D Prescriptions Filled, Including Refills

Rank: 350 out of 1383

$639K Total Retail Price of All Prescriptions

Rank: 211 out of 1383

375 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 375 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 375 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 7,010 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
PRAVASTATIN SODIUM 296 205 1 14
LEVOTHYROXINE SODIUM 290 259 2 4
AMLODIPINE BESYLATE 257 201 3 6
SIMVASTATIN 243 199 4 2
HYDROCODONE-ACETAMINOPHEN 236 148 S3 5 1
LISINOPRIL 226 156 6 3
FUROSEMIDE 208 157 7 7
CARVEDILOL 188 143 8 24
OMEPRAZOLE 186 143 9 5
POTASSIUM CHLORIDE 179 154 10 12
KLOR-CON M20 171 133 11 100
CRESTOR 160 96 12 34
METFORMIN HCL 152 97 13 8
ATENOLOL 144 103 14 16
CYMBALTA 142 68 15 53
HYDROCHLOROTHIAZIDE 136 99 16 10
INDAPAMIDE 113 102 17 153
NEXIUM 110 73 18 26
GABAPENTIN 109 68 19 11
ZETIA 97 67 20 101
JANUVIA 97 46 20 85
LOSARTAN POTASSIUM 95 83 22 23
METFORMIN HCL ER 94 62 23 47
METOPROLOL SUCCINATE 89 66 24 29
DILTIAZEM ER 88 76 25 110
DIOVAN 83 72 26 58
HYDROXYCHLOROQUINE SULFATE 76 63 27 264
FENOFIBRATE 75 62 28 65
ALLOPURINOL 72 56 29 33
TRAZODONE HCL 72 50 29 36
PLAVIX 72 65 29 43
TAMSULOSIN HCL 71 52 32 30
RANITIDINE HCL 68 37 33 19
KLOR-CON 10 67 50 34 74
NYSTATIN 66 50 35 132
ATORVASTATIN CALCIUM 65 50 36 18
LYRICA 65 42 36 72
INSULIN SYRINGE 64 49 38 83
AZITHROMYCIN 61 42 39 41
LIOTHYRONINE SODIUM 60 48 40 258
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 44 41 27
DILTIAZEM 24HR ER 58 35 42 161
PEN NEEDLE 57 52 43 147
BENAZEPRIL HCL 57 26 43 38
NOVOLOG FLEXPEN 55 35 45 229
PROAIR HFA 54 40 46 42
CLOPIDOGREL 53 42 47 28
MIRTAZAPINE 53 41 47 51
TRAMADOL HCL 53 30 47 25
LEVEMIR FLEXPEN 52 27 50 199
CLONIDINE HCL 51 35 51 44
PANTOPRAZOLE SODIUM 51 40 51 32
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 37 51 89
ACARBOSE 50 48 54 345
SINGULAIR 50 35 54 82
WARFARIN SODIUM 50 19 54 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.